DeSelm et al. found that knockout of Atg5 in ovariectomized (OVX) mice can prevent experimental postmenopausal osteoporosis by inhibiting the localization of LC3 at the ruffled border [56], suggesting minimizing MAP1LC3B levels as a potential strategy for OP treatment. Here, ATG5 is linked to postmenopausal osteoporosis.